Molecular Profiles Adds to its Early Development Expertise
Molecular Profiles is pleased to announce the appointment of Dr. Robert Harris to the position of Director, Early Development. This senior position will play a key lead in the expansion of Molecular Profiles’ pharmaceutical development services, which integrates preclinical CMC, solid state form optimisation and formulation development for early clinical trials through to the end of Phase II.
Rob brings over 30 years of pharmaceutical industrial experience of working in GMP environments for both commercial and investigational medicinal products at blue chip and small to medium sized companies. During his career he has successfully managed the development of over 50 new chemical entities.
Rob has a particular interest in formulation strategies for poorly water soluble drugs to enhance oral bioavailability. Having worked on many dosage forms for oral , inhaled, parenteral and topical delivery, Rob’s expertise complements the team at Molecular Profiles. Professor Martyn Davies Chairman of Molecular Profiles stated “I am delighted to have Rob join us and his experience will be valued in the continued expansion of our services.”
Molecular Profiles provides formulation development and advanced characterisation services to the pharmaceutical industry worldwide. Based in Nottingham in the UK, the company has a team of experts leading our pre-formulation and formulation development services. Coupled with this is our in-house expertise and advanced analytical suite of technologies which provide optimisation and selection of drug form and solve the late stage formulation development issues that arise for drug delivery systems.